Friday, August 27, 2010
Movetis NV, a European gastrointestinal (GI) specialty pharmaceutical company, has received a conditional offer from a Luxembourg incorporated wholly owned subsidiary of Shire plc, a global specialty biopharmaceutical company, to acquire
Wednesday, August 11, 2010
AstraZeneca has posted second quarter revenues of $8,178 million, an increase of 1%, compared with the same period last year, at constant exchange rates (CER).
Tuesday, August 10, 2010
Wasdell Packaging has invested more than £1.5 million into a new ISO Class 8 (Class 100,000) factory in Swindon (UK) that doubles its production capacity and boosts its employee numbers to more than 200.
Tuesday, August 10, 2010
Clavis Pharma, a Norwegian cancer drug development company, and its partner Clovis Oncology, Inc. announce that the first two patients have been recruited into a Phase II clinical study comparing CP-4126 (also known as CO-1.01) with gemcitabine
Tuesday, August 10, 2010
Leading pharmaceutical manufacturer, Aesica, has appointed Andrew Henderson as Business Development Manager at its head office in Newcastle (UK) and Anthony Allcock as Site Director at its Queenborough base (UK).